• 1. Emerging enantiomeric resolution materials with homochiral nano-fabrications
  Ji-Ping Wei Nanoscale, 2015,7, 11815-11832
• 2. Embedding heteroatoms: an effective approach to create porphyrin-based functional materials
  Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341
• 3. Dissolved oxygen sensor based on fluorescence quenching of oxygen-sensitive ruthenium complexes immobilized in sol–gel-derived porous silica coatings
  Analyst, 1996,121, 785-788
• 4. Enabling high-throughput single-animal gene-expression studies with molecular and micro-scale technologies
  Jason Wan Lab Chip, 2020,20, 4528-4538
• 5. Fe(ii)-Assisted one-pot synthesis of ultra-small core–shell Au–Pt nanoparticles as superior catalysts towards the HER and ORR?
  Yi Cao,Yujiao Xiahou,Lixiang Xing,Xiang Zhang,Hong Li,ChenShou Wu,Haibing Xia Nanoscale, 2020,12, 20456-20466

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Indoles and derivatives Carbazoles

Introduction to 9-Methyl-2,3,4,9-tetrahydro-1H-carbazol-1-one (CAS No. 1485-19-4)

9-Methyl-2,3,4,9-tetrahydro-1H-carbazol-1-one, also known by its CAS number 1485-19-4, is a significant compound in the field of organic chemistry and pharmaceutical research. This compound belongs to the class of carbazoles, which are heterocyclic aromatic compounds with a wide range of biological activities. The unique structure and properties of 9-Methyl-2,3,4,9-tetrahydro-1H-carbazol-1-one make it an important molecule for various applications in drug discovery and development.

The chemical structure of 9-Methyl-2,3,4,9-tetrahydro-1H-carbazol-1one consists of a carbazole core with a methyl group at the 9-position and a ketone group at the 1-position. This configuration imparts specific chemical and physical properties that are crucial for its biological activities. The compound is typically synthesized through multi-step processes involving the condensation of appropriate precursors and subsequent functional group modifications.

In recent years, significant research has been conducted to explore the potential therapeutic applications of 9-Methyl-2,3,4,9-tetrahydro-1H-carbazol-1-one. One of the key areas of interest is its anti-inflammatory properties. Studies have shown that this compound can effectively inhibit the production of pro-inflammatory cytokines such as TNF-alpha and IL-6 in vitro and in vivo. These findings suggest that 9-Methyl-2,3,4,9-tetrahydro-1H-carbazol-1-one could be a promising candidate for the treatment of inflammatory diseases such as rheumatoid arthritis and inflammatory bowel disease.

Beyond its anti-inflammatory effects, 9-Methyl-2,3,4,9-tetrahydro-1H-carbazol-1-one has also been investigated for its neuroprotective properties. Research has demonstrated that this compound can protect neurons from oxidative stress and apoptosis induced by various neurotoxic agents. These neuroprotective effects are attributed to its ability to modulate key signaling pathways involved in cell survival and death. Consequently, 9-Methyl-2,3,4,9-tetrahydro-1H-carbazol-1-one has potential applications in the treatment of neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease.

The pharmacokinetic properties of 9-Methyl-2,3,4,9-tetrahydro-1H-carbazol-1-one have also been studied to assess its suitability as a therapeutic agent. Preclinical studies have shown that this compound exhibits favorable absorption, distribution, metabolism, and excretion (ADME) profiles. It has good oral bioavailability and can cross the blood-brain barrier efficiently. These characteristics make it an attractive candidate for further clinical development.

In addition to its therapeutic potential, 9-Methyl-2,3,4,9-tetrahydro-1H-carbazol-1-one has been explored for its use in material science and organic synthesis. The unique electronic properties of carbazoles make them valuable building blocks for the synthesis of advanced materials such as organic semiconductors and luminescent materials. Recent advancements in synthetic methods have enabled the efficient production of this compound on a larger scale, facilitating its application in these fields.

The safety profile of 9-Methyl-2,3,4,9-tetrahydro-1H-carbazol-1-one is another critical aspect that has been evaluated in preclinical studies. Toxicological assessments have shown that this compound is generally well-tolerated at therapeutic doses with minimal adverse effects. However, further studies are needed to fully understand its long-term safety and potential interactions with other drugs.

In conclusion, 9-Methyl-2,3,4,9-tetrahydro-1H-carbazol-1-one (CAS No. 1485-19-4) is a versatile compound with a wide range of potential applications in pharmaceuticals and material science. Its anti-inflammatory and neuroprotective properties make it a promising candidate for the treatment of various diseases. Ongoing research continues to uncover new aspects of its biological activities and mechanisms of action, further highlighting its significance in both academic and industrial settings.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)